- Home
- FWRG vs OCUL Comparison
FWRG vs OCUL Comparison
Compare FWRG & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRG
- OCUL
- Stock Information
- Founded
- FWRG 1983
- OCUL 2006
- Country
- FWRG United States
- OCUL United States
- Employees
- FWRG N/A
- OCUL N/A
- Industry
- FWRG Restaurants
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- FWRG Consumer Discretionary
- OCUL Health Care
- Exchange
- FWRG Nasdaq
- OCUL Nasdaq
- Market Cap
- FWRG 1.0B
- OCUL 957.3M
- IPO Year
- FWRG 2021
- OCUL 2014
- Fundamental
- Price
- FWRG $19.59
- OCUL $7.31
- Analyst Decision
- FWRG Strong Buy
- OCUL Strong Buy
- Analyst Count
- FWRG 10
- OCUL 10
- Target Price
- FWRG $22.80
- OCUL $16.22
- AVG Volume (30 Days)
- FWRG 731.4K
- OCUL 1.9M
- Earning Date
- FWRG 05-06-2025
- OCUL 05-06-2025
- Dividend Yield
- FWRG N/A
- OCUL N/A
- EPS Growth
- FWRG N/A
- OCUL N/A
- EPS
- FWRG 0.30
- OCUL N/A
- Revenue
- FWRG $1,015,910,000.00
- OCUL $63,723,000.00
- Revenue This Year
- FWRG $21.47
- OCUL $13.32
- Revenue Next Year
- FWRG $15.96
- OCUL $13.13
- P/E Ratio
- FWRG $65.30
- OCUL N/A
- Revenue Growth
- FWRG 13.95
- OCUL 9.03
- 52 Week Low
- FWRG $12.90
- OCUL $4.06
- 52 Week High
- FWRG $25.98
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- FWRG 61.63
- OCUL 51.39
- Support Level
- FWRG $15.03
- OCUL $6.94
- Resistance Level
- FWRG $17.31
- OCUL $7.83
- Average True Range (ATR)
- FWRG 1.23
- OCUL 0.72
- MACD
- FWRG 0.37
- OCUL 0.07
- Stochastic Oscillator
- FWRG 94.80
- OCUL 74.57
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.